Cagrilintide 10mg Vial
Amylin-analogue style peptide • Satiety & appetite research
$180
per vial
Out of stock
View & buy →
About Cagrilintide 10mg Vial
Cagrilintide is an amylin-analogue style peptide that often appears in metabolic literature exploring fullness signalling and appetite-related endpoints.
In research discussions, Cagrilintide is typically positioned as an amylin-pathway analogue studied in combination with other incretin-pathway agents. Preclinical and early clinical papers frequently examine its role in satiety signalling, caloric intake, and body-weight trajectories over time. These works focus on mechanistic and observational endpoints rather than prescribing or therapeutic use.
Research themes
- Commonly combined with GLP-1 agonists in research protocols analysing multi-pathway appetite regulation.
- Used in models that track caloric intake, subjective satiety scales, and body-weight curves across extended observation windows.
- Frequently referenced in metabolic research programs evaluating full-stack incretin and amylin pathway engagement.
- Appears in discussions around long-term energy balance and food-seeking behaviour in controlled experimental settings.
Specifications
| Purity | ≥97% |
| MolecularWeight | 3963.4 g/mol |
| Form | Lyophilized powder |
| Storage | Store at -20°C, protect from light and moisture |
For research, reference and display purposes only. Not intended for human use. No medical advice, dosing protocols or therapeutic recommendations are provided.